Location History:
- Hohenwarte, DE (2007 - 2010)
- Hohenwarthe, DE (2008 - 2013)
Company Filing History:
7 out of 7 
2 out of 2 
1 out of 1 Years Active: 2007-2013
Title: Inventor Siegfried Ansorge: Pioneering Innovations in Peptidase Inhibitors
Introduction
Siegfried Ansorge, an accomplished inventor based in Hohenwarthe, Germany, has made significant contributions to the field of medicinal chemistry through his work on peptidase inhibitors. With a portfolio boasting 10 patents, his innovations focus on therapies for inflammatory and other diseases, highlighting his dedication to advancing medical treatments.
Latest Patents
Among his latest patents, Ansorge has developed dual-use peptidase inhibitors as prodrugs for the therapy of inflammatory and other diseases. These compounds, defined by the general formulae (1) and (2), represent a groundbreaking approach to treating conditions where immune response plays a pivotal role. His inventions also encompass dual alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors, which possess the capability to functionally influence different cells. This innovation targets immunological inflammatory diseases, neurological disorders, chronic-inflammatory conditions, skin diseases, tumor diseases, and even specific virus infections like SARS.
Career Highlights
Siegfried Ansorge's career is marked by his association with reputable companies such as Imtm Gmbh and Keyneurotek Pharmaceuticals AG. These firms have provided him with a platform to impact the pharmaceutical landscape positively, facilitating the development of his innovative compounds.
Collaborations
Throughout his career, Ansorge has collaborated with accomplished colleagues including Uwe Lendeckel and Klaus Neubert. These partnerships have enriched his research and fueled advancements in developing therapeutic options for complex medical challenges.
Conclusion
In conclusion, Siegfried Ansorge stands out as a prominent inventor in the realm of medicinal innovations. His commitment to creating effective treatments for diseases marked by excessive immune responses demonstrates the vital role of inventors in transforming healthcare. Through his patents and collaborations, Ansorge continues to pave the way for future advancements in the field of pharmacology.